GREAT REPEAL BILL
Britain details shift from EU laws after Brexit
Drug makers are concerned that Brexit will mean the UK leaves the EU-wide European Medicines Agency, forcing the creation of a separate British system for drug approvals
The British government has set out how it will handle the task of converting EU laws into domestic legislation in preparation for its exit from the bloc, seeking to ease business uncertainty about life after Brexit. On Wednesday, Prime Minister Theresa May formally notified Brussels of Britain’s intention to leave the EU after more than 40 years of membership, during which tens of thousands of EU-related laws have made their way onto the British statute book. On Thursday, her ministers set out how they intend to unpick that legislative web by initially converting the entire body of EU law into British law.
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.